20170406 Telix Logo.png
Telix Radiopharmaceutical Production Facility Buildout Commences
21 mars 2022 18h41 HE | Telix Pharmaceuticals Limited
MELBOURNE, Australia and BRUSSELS, Belgium, March 22, 2022 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) is pleased to provide a material update on the development...
20170406 Telix Logo.png
EAU Updates Guidance for PSMA-PET Imaging
21 mars 2022 01h28 HE | Telix Pharmaceuticals Limited
MELBOURNE, Australia and LIÈGE, Belgium, March 21, 2022 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) welcomes the updated 2022 ‘Guidelines on Prostate...
20170406 Telix Logo.png
ZIRCON Phase III Kidney Cancer Imaging Study Completes Target Enrolment
07 mars 2022 17h37 HE | Telix Pharmaceuticals Limited
MELBOURNE, Australia, March 08, 2022 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, “Telix”, the “Company”) today announces that ZIRCON (Zirconium in Renal Cancer Oncology,...
20170406 Telix Logo.png
Telix Enters Commercial Distribution Agreement for Illuccix® in Australia
15 févr. 2022 17h39 HE | Telix Pharmaceuticals Limited
MELBOURNE, Australia, Feb. 15, 2022 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces that it has entered into a commercial distribution agreement with...
20170406 Telix Logo.png
Telix and SHINE partner for Lutetium-177 Supply
10 févr. 2022 16h09 HE | Telix Pharmaceuticals Limited
MELBOURNE, Australia and INDIANAPOLIS, Feb. 10, 2022 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces a new global clinical supply agreement with...
20170406 Telix Logo.png
Telix Expands Lutetium-177 Network with Eckert & Ziegler Clinical Supply Agreement
08 févr. 2022 17h27 HE | Telix Pharmaceuticals Limited
MELBOURNE and LIEGE, Belgium, Feb. 08, 2022 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces a global clinical supply agreement with Berlin-based...
20170406 Telix Logo.png
Telix and Biokosmos Sign Distribution Agreement for Prostate Cancer Imaging in Greece and Cyprus
27 janv. 2022 16h41 HE | Telix Pharmaceuticals Limited
MELBOURNE, Australia and ATHENS, Greece, Jan. 28, 2022 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces that it has entered into an exclusive...
20170406 Telix Logo.png
First Patient Dosed in ProstACT Program for Prostate Cancer Therapy
26 janv. 2022 16h51 HE | Telix Pharmaceuticals Limited
MELBOURNE, Australia, Jan. 26, 2022 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces that the first patient has been dosed in the Company’s...
20170406 Telix Logo.png
Raphaël Ortiz Joins Telix as Chief Operating Officer, EMEA
25 janv. 2022 01h29 HE | Telix Pharmaceuticals Limited
MELBOURNE, Australia and LIÈGE Belgium, Jan. 25, 2022 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces that Raphaël Ortiz has joined the Company...
20170406 Telix Logo.png
Telix Collaborates with Olivia Newton-John Cancer Research Institute on Brain Cancer Imaging Study
21 déc. 2021 19h49 HE | Telix Pharmaceuticals Limited
MELBOURNE, Australia, Dec. 22, 2021 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces that it has entered into a clinical data access agreement with...